Viewing nowCombinationEmpagliflozin 25/5 mg (Empagliflozin, Linagliptin (Unmodified))
Empagliflozin 25mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.

MFDS item code 202502505 · Approved 2025.09.22 · Insurance code 646005870
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps improve blood glucose control in patients with type 2 diabetes. It assists in better blood glucose management when used alongside dietary and exercise therapies. It is especially suitable for improving blood glucose control through the combination use of empagliflozin and linagliptin. Therefore, this medication is used for the treatment of patients with type 2 diabetes.
The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. For patients who tolerate empagliflozin 10 mg/linagliptin 5 mg but require additional glycemic control, the dose of this drug may be increased to 25/5 mg once daily. Patients switching from concomitant therapy with empagliflozin and linagliptin to this drug should receive the same doses they were taking previously. This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose of this drug, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. This drug is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2. No dose adjustment is required for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is required based on age. In patients 75 years of age or older, renal function and the risk of volume depletion should be considered.
This medication should not be used in certain patients. For example, those with allergies to the active ingredients or constituents of this medication, patients with type 1 diabetes, diabetic ketoacidosis patients, and those undergoing dialysis should not take this medication. For patients with impaired renal function, the effects of this medication may vary, so it is important to regularly check renal function before and during treatment. Caution is also needed if other medications that may affect renal function are being taken. Experience with this medication is limited in heart failure patients, so it should be used with caution. There is a risk of acute pancreatitis, so if symptoms such as severe abdominal pain occur, the medication should be stopped immediately and a doctor consulted. A skin condition called bullous pemphigoid may occur, and if blisters or rashes appear on the skin, immediate medical attention from a specialist should be sought. The most common side effect while taking this medication is urinary tract infection, but other side effects may include hypoglycemia, thirst, cough, constipation, itching, rashes, rhabdomyolysis, depletion of blood volume, increased urination, difficulty urinating, increased amylase, increased lipase, increased hematocrit, increased serum lipids, increased blood creatinine, headache, dizziness, drowsiness, weight gain, ECG abnormalities, and decreased hemoglobin. Especially when used alongside insulin or sulfonylureas, the risk of hypoglycemia may increase, so blood glucose levels should be monitored closely. This medication may cause a decrease in fluid volume, so caution is needed in the elderly, those with low blood pressure, or patients with cardiovascular diseases. The risk of genital fungal infections may increase, so treatment should be sought if related symptoms appear. It is advisable not to use this medication during pregnancy or breastfeeding, and especially during breastfeeding, it is recommended to discontinue breastfeeding. The safety and efficacy of this medication have not been established in children under 18 years of age, so it is not recommended. In case of overdose, immediate contact with a medical institution is required for appropriate actions, and it is difficult to remove this medication through blood dialysis. This medication should be stored out of the reach of children and kept in its original container for safety. Finally, caution should be exercised during driving or operating machinery while taking this medication due to the risk of hypoglycemia.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to store the medication at a cool room temperature between 1 to 30 degrees Celsius. Avoid storing it in excessively hot or cold places.
Pink film-coated tablets that are convex on both sides
Box - 30 tablets/box [10 tablets/PTP x 3], Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 25mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
CombinationLinagliptin Micronized 5mg · Empagliflozin 25mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Green Cross
CombinationLinagliptin Micronized 5mg · Empagliflozin 10mg
Tablet · Prescription medication · Combination
Green Cross Corporation
CombinationEmpagliflozin 10mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
Empagliflozin 10mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Cheil Pharmaceutical Co., Ltd.
Empagliflozin 25mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.